The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
MEPE has the properties of an osteoblastic phosphatonin and minhibin
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Self-citationREINHARDT, T. A., HORST, R. L., ORF, J. W., & HOLLIS, B. W. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-1-91 · Cited by 801
Flexible Structures of SIBLING Proteins, Bone Sialoprotein, and Osteopontin
Fisher, L. W., Torchia, D. A., Fohr, B., Young, M. F., & Fedarko, N. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4146 · Cited by 654
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 554
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304544200 · Cited by 508
Self-citationToomes, C., James, J., Wood, A. J., Wu, C. L., McCormick, D., Lench, N., Hewitt, C., Moynihan, L., Roberts, E., Woods, C. G., et al. (1999) · Nature Genetics · doi:10.1038/70525 · Cited by 496
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
White, K. E., Carn, G., Lorenz-Depiereux, B., Benet-Pages, A., Strom, T. M., & Econs, M. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00064.x · Cited by 493
The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
Turner, A. J., Isaac, R. E., & Coates, D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3<261::aid-bies1036>3.0.co;2-k · Cited by 452
Shimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Saito, H., Kusano, K., Kinosaki, M., Ito, H., Hirata, M., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207872200 · Cited by 414
Chen, D., Ji, X., Harris, M. A., Feng, J. Q., Karsenty, G., Celeste, A. J., Rosen, V., Mundy, G. R., & Harris, S. E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.295 · Cited by 382
Self-citationHock, J. M., & Gera, I. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070110 · Cited by 367
MEPE, a New Gene Expressed in Bone Marrow and Tumors Causing Osteomalacia
Rowe, P. S. N., de Zoysa, P. A., Dong, R., Wang, H. R., White, K. E., Econs, M. J., & Oudet, C. L. (2000) · Genomics · doi:10.1006/geno.2000.6235 · Cited by 363
Self-citationFGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate
Bowe, A. E., Finnegan, R., Jan de Beur, S. M., Cho, J., Levine, M. A., Kumar, R., & Schiavi, S. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5084 · Cited by 344
Osteopontin Deficiency Increases Mineral Content and Mineral Crystallinity in Mouse Bone
Boskey, A. L., Spevak, L., Paschalis, E., Doty, S. B., & McKee, M. D. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-1121-z · Cited by 332
White, K. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.497 · Cited by 329
Gowen, L. C., Petersen, D. N., Mansolf, A. L., Qi, H., Stock, J. L., Tkalcevic, G. T., Simmons, H. A., Crawford, D. T., Chidsey-Frink, K. L., Ke, H. Z., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203250200 · Cited by 298
Wesson, J. A., Johnson, R. J., Mazzali, M., Beshensky, A. M., Stietz, S., Giachelli, C., Liaw, L., Alpers, C. E., Couser, W. G., Kleinman, J. G., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000040593.93815.9d · Cited by 295
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent
Berndt, T., Craig, T. A., Bowe, A. E., Vassiliadis, J., Reczek, D., Finnegan, R., Jan De Beur, S. M., Schiavi, S. C., & Kumar, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18563 · Cited by 293
Schlesinger, D. H., & Hay, D. I. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40603-x · Cited by 292
Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells
Bhargava, U., Bar-Lev, M., Bellows, C. G., & Aubin, J. E. (1988) · Bone · doi:10.1016/8756-3282(88)90005-1 · Cited by 279
Bai, X.-Y., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 276
Raj, P. A., Johnsson, M., Levine, M. J., & Nancollas, G. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42650-6 · Cited by 256
Octreotide Therapy for Tumor-Induced Osteomalacia
Seufert, J., Ebert, K., Müller, J., Eulert, J., Hendrich, C., Werner, E., Schütze, N., Schulz, G., Kenn, W., Richtmann, H., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010839 · Cited by 234
Anabolic Therapy for Osteoporosis
Rosen, C. J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.957 · Cited by 227
Nesbitt, T., Coffman, T. M., Griffiths, R., & Drezner, M. K. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115735 · Cited by 219
Self-citationTumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
De Beur, S. M. J., Finnegan, R. B., Vassiliadis, J., Cook, B., Barberio, D., Estes, S., Manavalan, P., Petroziello, J., Madden, S. L., Cho, J. Y., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1102 · Cited by 212
Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice
Dr. Meyer, R. A., Meyer, M. H., & Gray, R. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040407 · Cited by 209
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)
Rowe, P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.539 · Cited by 200
Self-citationZhao, M., Harris, S. E., Horn, D., Geng, Z., Nishimura, R., Mundy, G. R., & Chen, D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109012 · Cited by 170
Self-citationMiao, D., Bai, X., Panda, D., McKee, M. D., Karaplis, A. C., & Goltzman, D. (2001) · Endocrinology · doi:10.1210/endo.142.2.7976 · Cited by 162
Argiro, L., Desbarats, M., Glorieux, F. H., & Ecarot, B. (2001) · Genomics · doi:10.1006/geno.2001.6553 · Cited by 153
Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group Protein
Lee, S., Lin, M., Mele, A., Cao, Y., Farmar, J. G., Russo, D., & Redman, C. M. (1999) · Blood · doi:10.1182/blood.v94.4.1440 · Cited by 149
Parathyroid Hormone Temporal Effects on Bone Formation and Resorption
Kroll, M. H. (2000) · Bulletin of Mathematical Biology · doi:10.1006/bulm.1999.0146 · Cited by 145
Tenenhouse, H. S. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.2.333 · Cited by 143
Comparative Analysis of Mammalian Stanniocalcin Genes
Varghese, R., Wong, C. K. C., Deol, H. K., Wagner, G. F., & DiMattia, G. E. (1998) · Endocrinology · doi:10.1210/endo.139.11.6313 · Cited by 140
Ruchon, A. F., Tenenhouse, H. S., Marcinkiewicz, M. M., Siegfried, G., Aubin, J. E., DesGroseillers, L., Crine, P., & Boileau, G. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1440 · Cited by 138
Meyer, R. A., Meyer, M. H., Tenenhouse, H. S., & Klugerman, A. H. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040411 · Cited by 125
Petersen, D. N., Tkalcevic, G. T., Mansolf, A. L., Rivera-Gonzalez, R., & Brown, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003622200 · Cited by 123
Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice
Varghese, R., Gagliardi, A. D., Bialek, P., Yee, S., Wagner, G. F., & DiMattia, G. E. (2002) · Endocrinology · doi:10.1210/endo.143.3.8671 · Cited by 123
Maheshwari, R., Bhutani, N., & Suneja, P. (2019) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2019.70502 · Cited by 123
Hoyer, J. R., Asplin, J. R., & Ötvös, L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00772.x · Cited by 121
Miyauchi, A., Fukase, M., Tsutsumi, M., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-46 · Cited by 120
Inhibition of MEPE cleavage by Phex
Guo, R., Rowe, P. S., Liu, S., Simpson, L. G., Xiao, Z.-S., & Quarles, L. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02125-3 · Cited by 120
Self-citationOncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins, G. E., Granleese, S. R., Hegele, R. G., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745010 · Cited by 114
Intrinsic mineralization defect inHyp mouse osteoblasts
Xiao, Z., Crenshaw, M. A., Guo, R., Nesbitt, T., Drezner, M. K., & Quarles, L. D. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e700 · Cited by 114
Self-citationOursler, M. J., Riggs, B. L., & Spelsberg, T. C. (1993) · Endocrinology · doi:10.1210/endo.133.5.8404670 · Cited by 111
Guo, R., & Quarles, L. D. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1009 · Cited by 108
Self-citationEcarot, B., Glorieux, F. H., Desbarats, M., Travers, R., & LaBelle, L. A. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070213 · Cited by 103
Bai, X., Miao, D., Panda, D., Grady, S., McKee, M. D., Goltzman, D., & Karaplis, A. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0113 · Cited by 100
Campos, M., COUTURE, C., Hirata, I. Y., Juliano, M. A., Loisel, T. P., Crine, P., Juliano, L., Boileau, G., & Carmona, A. K. (2003) · Biochemical Journal · doi:10.1042/bj20030287 · Cited by 98
Ontogeny of Phex/PHEX Protein Expression in Mouse Embryo and Subcellular Localization in Osteoblasts
Thompson, D., Sabbagh, Y., Tenenhouse, H. S., Roche, P. C., Drezner, M. K., Salisbury, J. L., Grande, J. P., Poeschla, E. M., & Kumar, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.311 · Cited by 97
Self-citationA peptide that inhibits hydroxyapatite growth is in an extended conformation on the crystal surface
Long, J. R., Dindot, J. L., Zebroski, H. A., Kiihne, S., Clark, R. H., Campbell, A. A., Stayton, P. S., & Drobny, G. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12083 · Cited by 94
Overexpression of Phex in Osteoblasts Fails to Rescue the Hyp Mouse Phenotype
Liu, S., Guo, R., Tu, Q., & Quarles, L. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107707200 · Cited by 91
Self-citationMacDougall, M. J., Simmons, D., Gu, T., & Dong, J. (2002) · Connective Tissue Research · doi:10.1080/03008200290000556 · Cited by 87
Boileau, G., Tenenhouse, H. S., DesGroseillers, L., & Crine, P. (2001) · Biochemical Journal · doi:10.1042/bj3550707 · Cited by 82
Analysis of recombinant Phex: an endopeptidase in search of a substrate
Guo, R., Liu, S., Spurney, R. F., & Quarles, L. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e837 · Cited by 81
Self-citationLajeunesse, D., Meyer, R. A., & Hamel, L. (1996) · Kidney International · doi:10.1038/ki.1996.468 · Cited by 74
1,25-(OH)2D3Down-Regulates Expression ofPhex, a Marker of the Mature Osteoblast1
Ecarot, B., & Desbarats, M. (1999) · Endocrinology · doi:10.1210/endo.140.3.6593 · Cited by 71
Walton, R. J., Russell, R. G. G., & Smith, R. F. (1975) · Clinical Science · doi:10.1042/cs0490045 · Cited by 70
Osteocalcin Production in Primary Osteoblast Cultures Derived from Normal and Hyp Mice
Carpenter, T. O., Moltz, K. C., Ellis, B. K., Andreoli, M., McCarthy, T. L., Bryan, D., & Gundberg, C. M. (1998) · Endocrinology · doi:10.1210/endo.139.1.5677 · Cited by 62
Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
Ev, M., Yates, A. J., Beneton, M. N. C., Galloway, J. R., Harris, S. T., & Kanis, J. A. (1987) · PubMed · Cited by 62
Rowe, P. S., Goulding, J. N., Summerfield, T. C., O'Riordan, J. L. H., Francis, F., Lehrach, H. R., Oudet, O., Hanauer, A., Econs, M. J., Drezner, M. K., et al. (1996) · Human Genetics · doi:10.1007/bf02185769 · Cited by 57
Self-citationRowe, P. S., Ong, A. C. M., Cockerill, F. J., Goulding, J. N., & Hewison, M. (1996) · Bone · doi:10.1016/8756-3282(95)00458-0 · Cited by 56
Self-citationNesbitt, T., Econs, M. J., Byun, J. K., Martel, J., Tenenhouse, H. S., & Drezner, M. K. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100909 · Cited by 54
Self-citationNesbitt, T., Fujiwara, I., Thomas, R. F., Xiao, Z., Quarles, L. D., & Drezner, M. K. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2027 · Cited by 53
Self-citationAction of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats
Bonjour, J., Trechsel, U., Fleisch, H. A., Schenk, R., Hf, D., & Baxter, L. (1975) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1975.229.2.402 · Cited by 52
Ecarot, B., Glorieux, F. H., Desbarats, M., Travers, R., & LaBelle, L. A. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070508 · Cited by 49
Zhu, X., Luo, C., Ferrier, J., & Sodek, J. (1997) · Biochemical Journal · doi:10.1042/bj3230637 · Cited by 43
Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells
Jonsson, K., Mannstadt, M., Miyauchi, A., et al. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690613 · Cited by 41
Szczepanska-Konkel, M., Yusufi, A. N. K., & Dousa, T. P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47517-5 · Cited by 39
Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats.
Trechsel, U., Schenk, R., Bonjour, J. ‐., Russell, R. G. G., & Fleisch, H. A. (1977) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1977.232.3.e298 · Cited by 39
Ecarot, B., Glorieux, F. H., Desbarats, M., et al. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100313 · Cited by 37
Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3
Yamamoto, T., Ecarot, B., & Glorieux, F. H. (1992) · Bone · doi:10.1016/8756-3282(92)90199-7 · Cited by 35
Mechanism of phosphaturia elicited by administration of phosphonoformate in vivo
VanScoy, M., Loghman‐Adham, M., Onsgard, M. J., Szczepanska-Konkel, M., Homma, S., Knox, F. G., & Dousa, T. P. (1988) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1988.255.5.f984 · Cited by 31
Skeletal Casein Kinase Activity Defect in the HYP Mouse
Rifas, L., Cheng, S.-L., Halstead, L. R., Gupta, A., Hruska, K. A., & Avioli, L. V. (1997) · Calcified Tissue International · doi:10.1007/s002239900331 · Cited by 31
Aisa, M. C. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(95)00182-4 · Cited by 31
Effects of PHEX Antisense in Human Osteoblast Cells
Shih, N. J. R., Jo, O. D., & Yanagawa, N. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132394 · Cited by 30
Ullrich, K. J., Rumrich, G., Burke, T. R., Shirazi‐Beechey, S. P., & Lang, H. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37173-3 · Cited by 28
Diphosphonates and phosphate homoeostasis in man
McCloskey, E. V., Yates, A. J. P., Gray, R. E., Hamdy, N. A. T., Galloway, J. H., & Kanis, J. А. (1988) · Clinical Science · doi:10.1042/cs0740607 · Cited by 28
Fujiwara, I., Aravindan, R. G., Horst, R. L., & Drezner, M. K. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.3.434 · Cited by 24
Self-citationRifas, L., Gupta, A. S., Hruska, K. A., & Avioli, L. V. (1995) · Calcified Tissue International · doi:10.1007/bf00298998 · Cited by 23
Effect of diphosphonate treatment on phosphate transport by renal brush border vesicles
Stoll, R., Fleisch, H. A., & Bonjour, J. ‐. (1980) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1980.239.1.f13 · Cited by 22
Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice
Rifas, L., Dawson, L. L., Halstead, L. R., et al. (1994) · Calcified Tissue International · doi:10.1007/bf00334333 · Cited by 21
Dual action of phosphonoformic acid on Na(+)-phosphate cotransport in opossum kidney cells
Loghman‐Adham, M., & Dousa, T. P. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.2.f301 · Cited by 21
Nelson, A. E., Hogan, J. J., Holm, I. A., et al. (2001) · Bone · doi:10.1016/s8756-3282(01)00417-3 · Cited by 17
Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man
Lawson-Matthew, P. J., Guilland-Cumming, D. F., Yates, A. J. P., Russell, R. G. G., & Kanis, J. А. (1988) · Clinical Science · doi:10.1042/cs0740101 · Cited by 16
1,25-(OH)2D3 Down-Regulates Expression of Phex, a Marker of the Mature Osteoblast
Ecarot, B. (1999) · Endocrinology · doi:10.1210/en.140.3.1192 · Cited by 16
Dubois, S. G., Ruchon, A. F., Delalandre, A., Boileau, G., & Lajeunesse, D. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00135.2002 · Cited by 15
Mühlbauer, R. C., Bonjour, J., & Fleisch, H. A. (1981) · Clinical Science · doi:10.1042/cs0600171 · Cited by 11
Cited by
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Phosphorylated Proteins and Control over Apatite Nucleation, Crystal Growth, and Inhibition
George, A., & Veis, A. (2008) · Chemical Reviews · doi:10.1021/cr0782729 · Cited by 745
Topaz, O., Shurman, D. L., Bergman, R., Indelman, M., Ratajczak, P., Mizrachi, M., Khamaysi, Z., Behar, D., Petronius, D., Friedman, V., et al. (2004) · Nature Genetics · doi:10.1038/ng1358 · Cited by 596
Regulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Self-citationSitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 542
Metadata
- Authors
- Rowe, P. S. N., Kumagai, Y., Gutierrez, G., Garrett, I. R., Blacher, R., Rosen, D., Cundy, J., Navvab, S., Chen, D., Drezner, M. K., Quarles, L. D., & Mundy, G. R.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 34
- Issue
- 2
- Pages
- 303-319
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W1973380233
- Cited by
- 268
- References
- 93
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.